1. Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study
- Author
-
Abdimadiyeva Aigerim, Sang Won Park, Jooyeon Lee, Wan Beom Park, Jeong-Sun Yang, Yeon Sook Kim, Yuri Kim, Hyoree Park, Yen Thi Hai Nguyen, Ji-Young Rhee, Jae-Phil Choi, Nam Hyuk Cho, Shinhye Cheon, Dong-Gyun Lim, Yeonjae Kim, and Uni Park
- Subjects
0301 basic medicine ,Microbiology (medical) ,Middle East respiratory syndrome coronavirus ,030106 microbiology ,Antibodies, Viral ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,030212 general & internal medicine ,Seroconversion ,Neutralizing antibody ,biology ,business.industry ,Outbreak ,General Medicine ,medicine.disease ,Antibodies, Neutralizing ,Virology ,Pneumonia ,Titer ,Infectious Diseases ,Spike Glycoprotein, Coronavirus ,Middle East Respiratory Syndrome Coronavirus ,biology.protein ,Middle East respiratory syndrome ,Original Article ,Antibody ,Coronavirus Infections ,business ,Follow-Up Studies - Abstract
Objectives We aimed to assess the longevity of spike-specific antibody responses and neutralizing activity in the plasma of recovered Middle East respiratory syndrome (MERS) patients. Methods We traced the antibody responses and neutralizing activity against MERS coronavirus (MERS-CoV) in peripheral blood samples collected from 70 recovered MERS patients for 5 years after the 2015 MERS outbreak in South Korea. We also measured the half-life of neutralizing antibody titres in the longitudinal specimens. Results The seropositivity rate persisted for up to 4 years (50.7–56.1%), especially in MERS patients who suffered from severe pneumonia, and then decreased (35.9%) in the fifth year. Although the spike-specific antibody responses decreased gradually, the neutralizing antibody titres decreased more rapidly (half-life: 20 months) in 19 participants without showing negative seroconversion during the study period. Only five (26.3%) participants had neutralizing antibody titres greater than 1/1000 of PRNT50, and a high neutralizing antibody titre over 1/5000 was not detected in the participants at five years after infection. Discussion The seropositivity rate of the recovered MERS patients persisted up to 4 years after infection and significantly dropped in the fifth year, whereas the neutralizing antibody titres against MERS-CoV decreased more rapidly and were significantly reduced at 4 years after infection.
- Published
- 2022